Browse > Article
http://dx.doi.org/10.5483/BMBRep.2014.47.4.140

Characterization of a novel posttranslational modification in polypyrimidine tract-binding proteins by SUMO1  

Han, Wei (The State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College)
Wang, Lin (The State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College)
Yin, Bin (The State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College)
Peng, Xiaozhong (The State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College)
Publication Information
BMB Reports / v.47, no.4, 2014 , pp. 233-238 More about this Journal
Abstract
Polypyrimidine tract-binding protein 1 (PTBP1) and its brain-specific homologue, PTBP2, are associated with pre-mRNAs and influence pre-mRNA processing, as well as mRNA metabolism and transport. They play important roles in neural differentiation and glioma development. In our study, we detected the expression of the two proteins in glioma cells and predicted that they may be sumoylated using SUMOplot analyses. We confirmed that PTBP1 and PTBP2 can be modified by SUMO1 with co-immunoprecipitation experiments using 293ET cells transiently co-expressing SUMO1 and either PTBP1 or PTBP2. We also found that SUMO1 modification of PTBP2 was enhanced by Ubc9 (E2). The mutation of the sumoylation site (Lys137) of PTBP2 markedly inhibited its modification by SUMO1. Interestingly, in T98G glioma cells, the level of sumoylated PTBP2 was reduced compared to that of normal brain cells. Overall, this study shows that PTBP2 is posttranslationally modified by SUMO1.
Keywords
Glioma; PTBP1; PTBP2; SUMO1; UBC9;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Sawicka, K., Bushell, M., Spriggs, K. A. and Willis, A. E. (2008) Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem. Soc. Trans. 36, 641-647.   DOI   ScienceOn
2 Polydorides, A. D., Okano, H. J., Yang, Y. Y. L., Stefani, G. and Darnell, R. B. (2000) A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. Proc. Natl. Acad. Sci. U.S.A. 97, 6350-6355.   DOI   ScienceOn
3 Markovtsov, V., Nikolic, J. M., Goldman, J. A., Turck, C. W., Chou, M. Y. and Black, D. L. (2000) Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol. Cell Biol. 20, 7463-7479.   DOI
4 Lillevali, K., Kulla, A. and Ord, T. (2001) Comparative expression analysis of the genes encoding polypyrimidine tract binding protein (PTB) and its neural homologue (brPTB) in prenatal and postnatal mouse brain. Mech. Dev. 101, 217-220.   DOI   ScienceOn
5 Licatalosi, D. D., Yano, M., Fak, J. J., Mele, A., Grabinski, S. E., Zhang, C. and Darnell, R. B. (2012) Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev. 26, 1626-1642.   DOI   ScienceOn
6 Keppetipola, N., Sharma, S., Li, Q. and Black, D. L. (2012) Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2. Crit. Rev. Biochem. Mol. Biol. 47, 360-378.   DOI   ScienceOn
7 Cheung, H. C., Hai, T., Zhu, W., Baggerly, K. A., Tsavachidis, S., Krahe, R. and Cote, G. J. (2009) Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain 132, 2277-2288.   DOI   ScienceOn
8 Zheng, S., Gray, E. E., Chawla, G., Porse, B. T., O'Dell, T. J. and Black, D. L. (2012) PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nat. Neurosci. 15, 381-388.   DOI   ScienceOn
9 Yap, K., Lim, Z. Q., Khandelia, P., Friedman, B. and Makeyev, E. V. (2012) Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. Genes Dev. 26, 1209-1223.   DOI   ScienceOn
10 McCutcheon, I. E., Hentschel, S. J., Fuller, G. N., Jin, W. and Cote, G. J. (2004) Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro. Oncol. 6, 9-14.   DOI   ScienceOn
11 Cheung, H. C., Corley, L. J., Fuller, G. N., McCutcheon, I. E. and Cote, G. J. (2006) Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod. Pathol. 19, 1034-1041.   DOI
12 Johnson, E. S. (2004) Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382.   DOI   ScienceOn
13 Hickey, C. M., Wilson, N. R. and Hochstrasser, M. (2012) Function and regulation of SUMO proteases. Nat. Rev. Mol. Cell Biol. 13, 755-766.   DOI   ScienceOn
14 Lee, J., Lee, Y., Lee, M. J., Park, E., Kang, S. H., Chung, C. H., Lee, K. H. and Kim, K. (2008) Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex. Mol. Cell. Biol. 28, 6056-6065.   DOI   ScienceOn
15 Yang, W., Wang, L., Roehn, G., Pearlstein, R. D., Ali-Osman, F., Pan, H., Goldbrunner, R., Krantz, M., Harms, C. and Paschen, W. (2013) Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival. Cancer Sci. 104, 70-77.   DOI   ScienceOn
16 Wilkinson, K. A. and Henley, J. M. (2010) Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 428, 133-145.   DOI   ScienceOn
17 Cimarosti, H., Lindberg, C., Bomholt, S. F., Ronn, L. C. and Henley, J. M. (2008) Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology. 54, 280-289.   DOI   ScienceOn
18 Grant, M. M. (2010) Identification of SUMOylated proteins in neuroblastoma cells after treatment with hydrogen peroxide or ascorbate. BMB Rep. 43, 720-725.   과학기술학회마을   DOI   ScienceOn
19 Mukhopadhyay, D. and Dasso, M. (2007) Modification in reverse: the SUMO proteases. Trends. Biochem. Sci. 32, 286-295.   DOI   ScienceOn
20 Boutz, P. L., Stoilov, P., Li, Q., Lin, C. H., Chawla, G., Ostrow, K., Shiue, L., Ares, M., Jr. and Black, D. L. (2007) A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 21, 1636-1652.   DOI   ScienceOn
21 Clower, C. V., Chatterjee, D., Wang, Z., Cantley, L. C., Vander Heiden, M. G. and Krainer, A. R. (2010) The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 1894-1899.   DOI   ScienceOn